$5.040
-0.164 (-3.26%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ZEPP Prediction & Forecast by Similar Chart Analysis
Alphio's ZEPP stock price prediction model matches the current Zepp Health Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.07 (+0.58%). The 1-week path is $5.15 (+2.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Zepp Health Corp Stock?
Zepp Health Corp is currently not a strong buy. The stock is trading at $5.04, with a low RSI of 40.77, indicating potential oversold conditions but also a lack of momentum. The forward P/E ratio is very low at 3.12, suggesting it may be undervalued, but the company has a significant risk with a year-to-date change of -82.02%, indicating severe price depreciation. The recent earnings report showed a net loss of $19.64 million, although revenues increased by 33.5% year-over-year, reflecting some operational improvement. However, the overall financial health remains concerning, with a gross margin of 37.71% and a negative net margin of -38.11%.
ZEPP stock price ended at $5.04 on Friday, after losing -3.26%
Zepp Health Corp (ZEPP) last closed at $5.04, losing -3.26%. These facts feed the 1-day and 1-week ZEPP price prediction above.
Forecast Drivers
Zepp Health Corp (ZEPP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ZEPP, ranked by similarity.
Seasonality analysis for ZEPP
Historically the probability of a positive August return for ZEPP is 33.33%. September offers the highest probability of a positive month at 51.22%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.